4/A

PRIMARY DOCUMENT

Company: RIGEL PHARMACEUTICALS INC
Filed: March 23, 2004
Period of Report: February 24, 2004
Accession Number: 0001018534-04-000003

View Document ↗ View on SEC.gov ↗